CMG Pharmaceutical Co., Ltd. (KOSDAQ: 058820)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,814.00
+10.00 (0.55%)
Jan 22, 2025, 3:00 PM KST
-19.02%
Market Cap 250.56B
Revenue (ttm) 94.36B
Net Income (ttm) 2.89B
Shares Out 138.89M
EPS (ttm) 10.72
PE Ratio 168.21
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 129,443
Average Volume 392,091
Open 1,804.00
Previous Close 1,804.00
Day's Range 1,803.00 - 1,824.00
52-Week Range 1,590.00 - 2,525.00
Beta 0.68
RSI 44.42
Earnings Date Mar 21, 2025

About CMG Pharmaceutical

CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutic... [Read more]

Industry Pharmaceutical Preparations
Founded 2001
Employees 273
Stock Exchange KOSDAQ
Ticker Symbol 058820
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.